GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
S

Synmosa Biopharma 4114.TWO · TWD

Health Care · Taipei Exchange · 🇹🇼 Taiwan

Compare

27.85

+2.39%

Close of 9 Nov 2026, in TWD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Synmosa Biopharma annual report

Figures from our data supplier

We don't hold this company's report document. It publishes it on its own website.

Company website ↗

Five-year highlights

In TWD.

FY2025FY2024FY2023FY2022FY2021
RevenueTWD 6.19bnTWD 5.55bnTWD 5.14bnTWD 4.39bnTWD 3.23bn
Operating incomeTWD 841.9mTWD 739.1mTWD 620.3m—TWD 185.2m
Net incomeTWD 821.8mTWD 684.7mTWD 594.8mTWD 799.1mTWD 303.9m
Free cash flowTWD 130.4mTWD 511.0mTWD 242.2mTWD 501.0mTWD 351.2m
Total assetsTWD 13.99bnTWD 12.30bnTWD 11.73bnTWD 11.20bnTWD 10.32bn
Shareholders' equityTWD 8.76bnTWD 7.21bnTWD 6.71bnTWD 5.31bnTWD 4.71bn

Sources and methodology

Data on this tab
SEC EDGAR and our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.